




Searching News Database: EKR Therapeutics
HSMN NewsFeed - 30 Jul 2015
Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics
Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics
HSMN NewsFeed - 13 Jun 2012
Seventh Sense Biosystems Appoints President and CEO and Closes $10 Million Series-A Financing
Seventh Sense Biosystems Appoints President and CEO and Closes $10 Million Series-A Financing
HSMN NewsFeed - 3 Mar 2010
EKR Therapeutics Appoints John Bailye as Interim President & Chief Executive Officer
EKR Therapeutics Appoints John Bailye as Interim President & Chief Executive Officer
HSMN NewsFeed - 22 Sep 2008
Teva Introduces Nicardipine HCl Injection in the United States; First Alternative to Cardene(R) I.V.
Teva Introduces Nicardipine HCl Injection in the United States; First Alternative to Cardene(R) I.V.
HSMN NewsFeed - 1 Aug 2008
EKR Therapeutics Receives Approval for Ready-to-Use Intravenous Bags of Cardene(R) I.V.
EKR Therapeutics Receives Approval for Ready-to-Use Intravenous Bags of Cardene(R) I.V.
HSMN NewsFeed - 28 Apr 2008
Quaker BioVentures Closes Second Fund with $420 Million in Total Commitments
Quaker BioVentures Closes Second Fund with $420 Million in Total Commitments
HSMN NewsFeed - 4 Feb 2008
EKR Therapeutics and PDL BioPharma Sign Asset Purchase Agreement for Cardiovascular Products
EKR Therapeutics and PDL BioPharma Sign Asset Purchase Agreement for Cardiovascular Products
HSMN NewsFeed - 15 Aug 2007
EKR Therapeutics Raises Over $13 Million in a Series C Financing Round From New and Existing Investors
EKR Therapeutics Raises Over $13 Million in a Series C Financing Round From New and Existing Investors
HSMN NewsFeed - 12 Oct 2006
EKR Therapeutics Acquires Exclusive License for Gelclair(R) from Helsinn Healthcare SA
EKR Therapeutics Acquires Exclusive License for Gelclair(R) from Helsinn Healthcare SA